We are comparing a new treatment, MB12, to Keytruda for patients with non-small cell lung cancer. The study aims to understand differences in effectiveness and safety between the two options.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced non-squamous non-small cell lung cancer (NSCLC) is a type of lung cancer that has spread beyond the lungs and is not of the squamous cell type. It can lead to serious health issues and requires specialized treatment.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
